AGENT™

Drug-Coated Balloon

TransPax™ Coating Technology

The AGENT™ Drug-Coated Balloon (DCB) optimises drug transfer to the target vessel’s tissue through its TransPax coating, a proprietary formulation of Paclitaxel (PTx) and a citrate ester excipient. With drug transfer optimized1, go into the case with confidence that your patients will receive the best care possible.

Join the Modern PCI Movement
Request a Sales Rep

Request a Sales Rep

 Submit your question

Submit your question

Optimized Drug Transfer

  • TransPaxTM coating ensures targeted delivery of Paclitaxel2.
  • Optimal dose of 2 µg/mm2 compared to 3 µg/mm2 of market leading DCBs3.

Tissue Absorption

By optimising the choice of excipient and the formulation, AGENT is able to achieve similar long term Paclitaxel levels with a 50% reduction in Paclitaxel loading compared to majority of DCB competitors on the market2.
Pharmacokinetic tissue level comparable to Taxus Stent over time2.
Graph of Paclitaxel Arterial Tissue levels for BSC Agent, BTK Pantera Lux and B.Braun SeQuent Please

Drug Dissolution

The Paclitaxel in TransPax coating is in crystalline form. This morphology has lower solubility than an amorphous form which allows the drug to be better absorbed by the vessel as the crystalline particles act as sustained reservoirs that lead to better tissue absorption4.
Graph showing difference in coating morphology
 
Top